A mechanism-based understanding of altered drug pharmacokinetics by gut microbiota

被引：0
|
作者：
Aneela Gulnaz
Ji-Eun Chang
Han-Joo Maeng
Kwang-Hee Shin
Kyeong-Ryoon Lee
Yoon-Jee Chae
机构：
[1] Woosuk University,College of Pharmacy
[2] Dongduk Women’s University,College of Pharmacy
[3] Gachon University,College of Pharmacy
[4] Kyungpook National University,College of Pharmacy, Research Institute of Pharmaceutical Sciences
[5] Korea Research Institute of Bioscience and Biotechnology,Laboratory Animal Resource Center
[6] University of Science and Technology,Department of Bioscience
[7] Woosuk University,Research Institute of Pharmaceutical Sciences
来源：
Journal of Pharmaceutical Investigation | 2023年 / 53卷
关键词：
Gut microbiota; Drug pharmacokinetics; Drug metabolizing enzymes; Drug transporters;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：73 / 92
页数：19
相关论文
共 50 条
  • [21] Thalidomide and lenalidomide: Mechanism-based potential drug combinations
    Vallet, Sonia
    Palumbo, Antonio
    Raje, Noopur
    Boccadoro, Mario
    Anderson, Kenneth C.
    LEUKEMIA & LYMPHOMA, 2008, 49 (07) : 1238 - 1245
  • [22] Risk Assessment of Mechanism-Based Inactivation in Drug-Drug Interactions
    Fujioka, Yasushi
    Kunze, Kent L.
    Isoherranen, Nina
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (09) : 1653 - 1657
  • [23] Attention Mechanism-Based Cognition-Level Scene Understanding
    Tang, Xuejiao
    Zhang, Wenbin
    Information (Switzerland), 2025, 16 (03)
  • [24] The Gut Microbiota-Brain Axis: Potential Mechanism of Drug Addiction
    Luo, Xiao
    Li, Hong
    Fan, Xuan
    Wu, Xiaocong
    Zhou, Ruiyi
    Lei, Yi
    Xue, Dan
    Yang, Fazheng
    Xu, Yu
    Wang, Kunhua
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2023, 23 (18) : 1782 - 1792
  • [25] Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice
    Deodhar, Malavika
    Al Rihani, Sweilem B.
    Arwood, Meghan J.
    Darakjian, Lucy
    Dow, Pamela
    Turgeon, Jacques
    Michaud, Veronique
    PHARMACEUTICS, 2020, 12 (09) : 1 - 18
  • [26] Altered gut microbiota in hepatocellular carcinoma: Insights into the pathogenic mechanism and preclinical to clinical findings
    Das, Bhrigu Kumar
    APMIS, 2022, 130 (12) : 719 - 740
  • [27] Towards a mechanism-based analysis of pharmacodynamic drug-drug interactions in vivo
    Jonker, DM
    Visser, SAG
    van der Graaf, PH
    Voskuyl, RA
    Danhof, M
    PHARMACOLOGY & THERAPEUTICS, 2005, 106 (01) : 1 - 18
  • [28] Mechanism-based pain diagnosis - Issues for analgesic drug development
    Woolf, CJ
    Max, MB
    ANESTHESIOLOGY, 2001, 95 (01) : 241 - 249
  • [29] Mechanism-Based Pharmacokinetic/Pharmacodynamic Model for THIOMAB™ Drug Conjugates
    Sukumaran, Siddharth
    Gadkar, Kapil
    Zhang, Crystal
    Bhakta, Sunil
    Liu, Luna
    Xu, Keyang
    Raab, Helga
    Yu, Shang-Fan
    Mai, Elaine
    Fourie-O'Donohue, Aimee
    Kozak, Katherine R.
    Ramanujan, Saroja
    Junutula, Jagath R.
    Lin, Kedan
    PHARMACEUTICAL RESEARCH, 2015, 32 (06) : 1884 - 1893
  • [30] Application of mechanism-based CYP inhibition for predicting drug-drug interactions
    Zhou, Zhi-Wei
    Zhou, Shu-Feng
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (06) : 579 - 605
12345